Introduction: The use of products to prevent or reduce alcohol hangovers is increasingly popular. The aim of this study was to evaluate and compare the alcohol hangover product markets of the United Kingdom, Australia and Japan.Methods: The website www.Amazon.com was searched, using the terms ‘hangover treatment’ and ‘hangover cure’, to identify hangover products sold in the United Kingdom, Australia and Japan. Dosage forms, ingredients and their amounts per serving were recorded and compared between the three countries.Results: The market evaluations for the United Kingdom and Australia each revealed N = 19 hangover products, and 24 hangover products were found for Japan. The products from the three markets were quite distinct, with none of the hangover products being marketed in all three countries. The most popular ingredients in United Kingdom were potassium (63.2%), sodium (57.9%) and vitamin C (52.6%). The most common ingredients in Australia were vitamin B1, vitamin B6, vitamin B12 and sodium (all 47.4%). In Japan, curcumin (45.8%), L‐ornithine (29.2%), vitamin C (20.8%) and vitamin B2 (20.8%) were the most popular ingredients. Most popular dosage forms also differed between the countries, with powders being most popular in the United Kingdom (42.1%), tablets in Japan (50.0%), and capsules (31.6%) and drinks (26.3%) in Australia.Discussion and Conclusions: Both ingredients and dosage forms of hangover products differed between the United Kingdom, Australia and Japan. Products also differed from the United States, illustrating the importance of cross‐cultural comparisons. As these are currently lacking, double‐blind, placebo‐controlled clinical trials are needed to demonstrate the efficacy and safety of marketed hangover products.
A 2019 study revealed more than 80 products available online with implied benefits to alcohol hangover. Since then, several developments may have influenced the market. In order to gauge the extent to which this may have changed in the ensuing 5 years, two market evaluations (25 March 2023 and 7 November 2024) were conducted via the online web shop www.amazon.com , using the search term “hangover treatment.” In 2023, there were 38 different hangover products available. The most common dosage forms were capsules (14) and tablets (6), and most frequently reported ingredients were dihydromyricetin (DHM, 52.6% of products), vitamin B1 (42.1%), vitamin B12 (42.1%), sodium (42.1%), and vitamin B6 (39.5%). Only one product contained N-acetyl L-cysteine. Exactly half of the marketed products (19, 50.0%) made illegal disease modification claims. The second market evaluation (7 November 2024) revealed 46 hangover products. The most common dosage forms were capsules (18) and transdermal patches (13), and the most frequently reported ingredients were vitamin B6 (56.5% of products), vitamin C (54.3%), vitamin B1 (50.0%), and vitamin B12 (50.0%). Also, DHM (47.8%) and milk thistle extract (47.8%) were popular. In conclusion, over the 5 years to 2024 the US hangover product market has dramatically changed, including a significant reduction in the number of marketed hangover products. DHM, vitamins, and minerals remained the most popular ingredients of hangover products. Illegal disease claims were made by 41.3% of the marketed products. Of concern, the efficacy to prevent or reduce alcohol hangover has not been demonstrated for any product on the US hangover market.
Objective: Tolerance to the acute effects of alcohol, i.e., feeling less intoxicated after consuming the same amount of alcohol, has been reported for individuals who regularly consume alcohol. In this study, it was investigated whether such tolerance also exists for experiencing the alcohol hangover. Methods: Data from five studies that assessed hangover frequency and hangover severity were combined (n = 924). Partial correlations were computed between hangover frequency and hangover severity, with age, sex, and weekly alcohol consumption as possible confounders. Results: A significant and positive correlation was found between hangover frequency and hangover severity (r = 0.692, p < 0.001). After correcting for sex, age, and weekly alcohol consumption, the partial correlation remained significant (r = 0.526, p < 0.001). Conclusions: The observed positive association between hangover frequency and hangover severity suggests a reverse tolerance: if hangovers are experienced more frequently, they are more severe.
Background: The COVID‐19 pandemic disrupted healthcare systems worldwide, including the postponement of non‐urgent care and reallocation of resources toward COVID‐19 patients. The aim of this study was to assess the impact of the first Dutch COVID‐19 lockdown on the initiation of new analgesic prescriptions. Methods: This study analysed dispensing data from 1890 Dutch pharmacies, covering approximately 96% of the population (5.46 million patients). The number of first‐time prescription analgesics dispensed (ATC2 N02 class, e.g., opioids, anilides) was compared between the first halves of 2019 and 2020. First‐time users were defined as patients who had not received the drug in the preceding year. Data were stratified by age group (children, adolescents, adults, elderly), sex and time periods: weeks 1–11 (pre‐lockdown 2020), 12–19 (lockdown) and 20–26 (post‐lockdown). Results: The total number of first‐time dispensed analgesic drugs was significantly lower in 2020 (367,094) than in 2019 (388,973, p = 0.021), with a notable reduction occurring during the lockdown period ( p = 0.003). Significant declines in first‐time dispensed analgesic drugs were observed among adolescents and adults during lockdown ( p < 0.001), particularly among females. In contrast, no significant changes were found among children and the elderly. The number of first‐time dispensed analgesic drugs during the pre‐ and post‐lockdown periods was comparable between the 2 years. Conclusion: Delayed healthcare during the lockdown was associated with a decrease in first‐time dispensed analgesic drugs, especially among adolescents and adults. This may indicate untreated pain or increased reliance on over‐the‐counter alternatives during this period. Significance Statement: This Nationwide Dutch study showed a significant decline in first‐time dispensed analgesic drugs during the first lockdown period of the COVID‐19 pandemic, especially among adolescents and adults. This may indicate untreated pain due to delayed healthcare or an increased reliance on over‐the‐counter alternatives during this period.
23 July 2025 in Current Medical Research and Opinion
Patient preferences for treatment characteristics-such as dosage form, taste, smell, and ingredients-play a key role in adherence, yet these preferences differ widely across cultures and are frequently overlooked in pharmaceutical development. Prescription medicines must meet strict safety and effectiveness standards, restricting flexibility, whereas over-the-counter supplements allow more freedom, though often without proven benefits. Developing diverse formulations is expensive and time-consuming, and patients need clear guidance to make informed choices without feeling overwhelmed or questioning their doctors. This tension highlights a disconnect between patient desires, scientific validation, and practical feasibility. We urge healthcare providers, pharmaceutical companies, and patients to engage in dialogue to discuss patient preferences and diversity in drug development. By creating treatments that reflect cultural needs and improving patient education, adherence and equity in healthcare can improve, provided the scientific, economic, and logistical hurdles are addressed effectively.
Immune fitness is defined as the capacity of the body to respond to health challenges (such as infections) by activating an appropriate immune response to promote health and prevent and resolve disease, which is essential for improving quality of life. Thus, immune fitness plays an essential role in health, and reduced immune fitness may be an important signal of increased susceptibility for disease. Lifestyle factors such as increased levels of alcohol consumption have been shown to negatively impact immune fitness. The alcohol hangover is the most frequently reported negative consequence of alcohol consumption and is defined as the combination of negative mental and physical symptoms, which can be experienced after a single episode of alcohol consumption, starting when blood alcohol concentration (BAC) approaches zero. Significant correlations have been reported between hangover severity and both immune fitness and biomarkers of systemic inflammation. The concepts of immune fitness and alcohol hangover are further linked by the fact that the inflammatory response to alcohol consumption plays an important role in the pathology of the alcohol hangover. Moreover, immune fitness has been related to the susceptibility of experiencing hangovers per se. It is therefore important to investigate the interrelationship between immune fitness and the alcohol hangover, and to identify possible predictor variables of both constructs. This data descriptor article describes a study that was conducted with adults living in the UK or Ireland, evaluating possible correlates and predictors of immune fitness and the alcohol hangover. Data on mood, personality, mental resilience, pain catastrophizing, and sleep were collected from n = 1178 participants through an online survey. Herein, the survey and corresponding dataset are described.